Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

Probably all up from here if we don't completely run out of money.

Tough to do worse than a market cap of $40M with a phase 3 ready drug along with a number of phase 2B contenders. That's setting aside the potential COVID secondary endpoints/combo treatments and anti-viral preclinical data.

NNVC has existed for 15 years on just pre-clinical anti-viral data.
It currently has a marketcap of $53M...over 20% more than IPIX.
It has had a market cap over $1B in 2008, 2011, 2014 and a pop to $700M in 2017.
In my mind NNVC is undoubtedly a fraud.

The right set of preclinical anti-viral data along with a small phase 2 with the right results could easily bring us back to those heights.

Go IPIX!